[Pharmacoeconomic Comparison Between Dupilumab and Tralokinumab for the Treatment of Atopic Dermatitis in Italy: A Cost-Per-Responder Analysis]. FE 2025, 26 (1). https://doi.org/10.7175/fe.v26i1.1571.